Lite Strategy (LITS) Return on Equity [ROE] (2011 - 2026)
Lite Strategy's Return on Equity [ROE] was -134.69% in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 44.60 percentage points from -90.09% a year earlier and down 51.50 percentage points from the prior quarter.
Powered by 
Analysis
Lite Strategy (LITS) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Return on Equity [ROE] at Lite Strategy came in at -226.49%, down 160.71 percentage points from FY2025.
- Return on Equity [ROE] shows a five-year change of -131.77 percentage points (FY2021 to FY2026).
- In earlier fiscal years, Return on Equity [ROE] was -65.78% in FY2025 (-127.60 pp), 61.82% in FY2024 (+148.59 pp), -86.76% in FY2023 (+60.87 pp) and -147.63% in FY2022 (-52.91 pp).
- The fiscal Q4 2026 figure marks the lowest quarterly Return on Equity [ROE] since fiscal Q3 2025.
- Compared with a year earlier, Return on Equity [ROE] was higher in three of the last eight quarters, with an average year-over-year change of -58.90 percentage points.
- The best year-over-year quarter for Return on Equity [ROE] over five years was fiscal Q1 2024 (a gain of 239.17 percentage points); the worst was fiscal Q1 2025 (a drop of 237.60 percentage points).
- Per Business Quant data, LITS's Return on Equity [ROE] in the three fiscal quarters before Q4 2026 was -83.19% (Q3 2026), -39.88% (Q2 2026) and -18.69% (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | - |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 4.66% |
| 10 | Lite Strategy | 33.50 Mn | 7.21 Mn | - | -97.87% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -97.87% |
| Jun 30, 2026 | -134.69% |
| Mar 31, 2026 | -83.19% |
| Dec 31, 2025 | -39.88% |
| Sep 30, 2025 | -18.69% |
| Jun 30, 2025 | -90.09% |
| Mar 31, 2025 | -154.24% |
| Dec 31, 2024 | -164.61% |
| Sep 30, 2024 | -160.81% |
| Jun 30, 2024 | 42.40% |
| Mar 31, 2024 | 47.37% |
| Dec 31, 2023 | 28.20% |
| Sep 30, 2023 | 76.79% |
| Jun 30, 2023 | -113.33% |
| Mar 31, 2023 | -95.23% |
| Dec 31, 2022 | -106.10% |
| Sep 30, 2022 | -162.37% |
| Jun 30, 2022 | -125.10% |
| Mar 31, 2022 | -105.81% |
| Dec 31, 2021 | -129.16% |
API Access
Lite Strategy Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=LITS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "LITS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=LITS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();